GB

Geetanjali Bhanudas Bendale

Active Director Director DIN 08720890
DIN 08720890 First appointment Mar 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2020
Shareholding value •••• Premium profile

About Geetanjali Bhanudas Bendale

Data last updated:

Geetanjali Bhanudas Bendale is a Director at Pharchem Private Limited (since 2020). The company operates in Pharma. Pharchem Private Limited reported revenue of ₹20.20 Cr (FY 2024).

DIN 08720890
Primary Designation Director
Industry Pharma
First Appointment 16 Mar 2020
Oldest Company Age 6 yrs
Largest company Pharchem Private Limited · ₹20.20 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharchem Private Limited U24100MH2020PTC337168
Director16 Mar 20202020₹20.20 Cr (FY 2024)Active

Board colleagues of Geetanjali Bhanudas Bendale

Directorship timeline

Open interactive timeline →
Pharchem Private Limited
Premium access

Shareholding and investment profile for Geetanjali Bhanudas Bendale

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Geetanjali Bhanudas Bendale

Geetanjali Bhanudas Bendale currently holds 1 directorship: Pharchem Private Limited (Director, since 16 Mar 2020, revenue ₹20.20 Cr (FY 2024)).

Geetanjali Bhanudas Bendale was first appointed on 16 Mar 2020 as Director at Pharchem Private Limited.

The current boards of Geetanjali Bhanudas Bendale's companies include Milind Balwant Save (Pharchem Private Limited), Nimish Manohar Patil (Pharchem Private Limited), Swarali Milind Save (Pharchem Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available